Bar-Shira, Anat <br/><br/>
Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.  [electronic resource] 

 -  Neurogenetics  Oct 2009 
 - 355-8 p.  digital 
<br/><br/> Publication Type: Historical Article; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1364-6753 
<br/><br/><label>Standard No.: </label>10.1007/s10048-009-0186-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Amino Acid Substitution<br/>Founder Effect<br/>Genetic Markers<br/>Genetic Predisposition to Disease<br/>Haplotypes<br/>History, Ancient<br/>Humans<br/>Jews--genetics<br/>Leucine-Rich Repeat Serine-Threonine Protein Kinase-2<br/>Parkinson Disease--genetics<br/>Point Mutation<br/>Protein Serine-Threonine Kinases--genetics